Q-Switched Nd:YAG in Macular Amyloidosis

Shahid Beheshti University of Medical Sciences

Status and phase: Completed; Phase 1

Conditions: Macular Amyloidosis

Treatments: Device: Laser Therapy

Study type: Interventional

Funder types: Other

Identifiers

NCT00353392

src-ost-1359

Details and patient eligibility

About

The purpose of this study is to determine whether Q-Switched Nd:YAG Laser therapy are effective in reduction of Cutaneous macular amyloidosis.

Full description

We treat the macular amyloidosis cases by Q-Switched Nd:YAG Laser and compare the before and after treatment situation by the photos and colorimetric assessment.

Sex: All

Ages: 18 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Macular amyloidosis confirmed cases

Exclusion criteria

• Pregnancy and breast feeding
• Over 18 years old

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind